Login / Signup

COVID-19: a pandemic experience that illuminates potential reforms to health research.

Hannah N KozlowskiMichael E FarkouhMeredith S IrwinLaszlo G RadvanyiAaron D SchimmerUri TaboriNorman D Rosenblum
Published in: EMBO molecular medicine (2020)
COVID-19 has halted research around the globe and forced researchers out of their laboratories. Non-emergency medical appointments were canceled. Ongoing clinical trials were challenged to create new modes of operation while public pressure mounted to find therapeutic options against COVID-19. Yet, the inability to conduct research during COVID-19 was overcome with cooperation, resource sharing, and compassion, which provides important lessons on how to improve health related research as we enter a new normal.
Keyphrases
  • coronavirus disease
  • sars cov
  • clinical trial
  • emergency medical
  • respiratory syndrome coronavirus
  • healthcare
  • mental health
  • randomized controlled trial
  • health information
  • phase ii
  • adverse drug